Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort

被引:12
|
作者
Jee, Adelle S. [1 ,2 ,3 ]
Parker, Matthew J. S. [2 ,3 ,4 ]
Bleasel, Jane F. [2 ,4 ]
Troy, Lauren K. [1 ,2 ]
Lau, Edmund M. [1 ,2 ]
Jo, Helen E. [1 ,2 ,3 ]
Teoh, Alan K. Y. [1 ,2 ,3 ]
Adelstein, Stephen [2 ,5 ,6 ]
Webster, Susanne [1 ]
Corte, Tamera J. [1 ,2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Dept Resp, Sydney, NSW, Australia
[2] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia
[3] Natl Hlth & Med Res Council NHMRC, Ctr Res Excellence Pulm Fibrosis, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Dept Rheumatol, Sydney, NSW, Australia
[5] NSW Hlth Pathol, Cent Immunol Lab, Sydney, NSW, Australia
[6] Royal Prince Alfred Hosp, Dept Clin Immunol & Allergy, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Interstitial lung disease; Connective tissue disease; Autoimmune diseases; Pulmonary fibrosis associated with collagen vascular disorders; Clinical research;
D O I
10.1159/000515396
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: The research term "interstitial pneumonia with autoimmune features" (IPAF) encompasses interstitial lung disease (ILD) patients with autoimmune features not meeting diagnostic criteria for a defined connective tissue disease (CTD). It remains unclear if IPAF is a distinct disease entity with implications for management and prognosis. We describe an Australian IPAF population and compare their baseline characteristics and outcomes with distinct cohorts of idiopathic interstitial pneumonia (IIP), CTD-ILD, and unclassifiable ILD. Methods: Review of 291 consecutive patients attending a specialist ILD clinic was performed. Patients with a diagnosis of IIP, CTD-ILD, and unclassifiable ILD by ILD-multidisciplinary meeting (ILD-MDM) were included. Patients meeting the IPAF criteria were identified. Baseline clinical data, survival, and progression were compared between ILD groups. Results: 226 patients were included, 36 meeting the IPAF criteria. IPAF patients demonstrated a high prevalence of autoantibodies to tRNA synthetase (35.3%), Ro52 (27.8%), and neutrophilic cytoplasmic antigens (ANCA; 20.0%). IPAF and CTD-ILD patients demonstrated similar clinical characteristics (mean age 66.6 and 63.7 years, respectively, female predominant, frequent CTD-manifestations). Lung function did not differ between ILD groups. Disease severity, pulmonary hypertension (PH), and ILD-MDM diagnosis were strong predictors of worse transplant-free survival (TFS). Meeting the IPAF criteria was not associated with TFS. Conclusions: We identified IPAF as a heterogeneous phenotype that overlaps considerably with CTD-ILD. Disease severity, PH, and ILD-MDM diagnosis were more powerful predictors of survival outcomes than meeting the IPAF criteria.
引用
收藏
页码:853 / 864
页数:12
相关论文
共 50 条
  • [1] Survival In Interstitial Pneumonia With Features Of Autoimmune Disease
    Assayag, D.
    Kim, E.
    Elicker, B.
    Golden, J.
    Jones, K. D.
    King, T. E.
    Koth, L. L.
    Wolters, P. J.
    Collard, H. R.
    Lee, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] Idiopathic Interstitial Pneumonia With Autoimmune Features: Clinical Characteristics And Prognosis In A French Cohort
    Ahmad, K.
    Barba, T.
    Traclet, J.
    Khouatra, C.
    Cottin, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] A Multidisciplinary Cohort of Patients with Interstitial Pneumonia with Autoimmune Features
    Schroeder, Gabriel
    Barnado, April
    Annapureddy, Narender
    Dudenhofer, Rosemarie
    Crofford, Leslie
    Wilfong, Erin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Clinical Characteristics And Prognosis Of Interstitial Pneumonia With Autoimmune Features
    Lee, J.
    Lee, J.
    Song, J.
    Chae, E.
    Kim, D.
    Song, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Characteristics and risk factors of interstitial pneumonia with autoimmune features
    Vahidy, Sana
    Agyeman, Jonathan
    Zheng, Boyang
    Donohoe, Kathryn
    Hambly, Nathan
    Johannson, Kerri A.
    Assayag, Deborah
    Fisher, Jolene H.
    Manganas, Helene
    Marcoux, Veronica
    Khalil, Nasreen
    Kolb, Martin
    Ryerson, Christopher J.
    Wong, Alyson W.
    Lok, Stacey
    Morisset, Julie
    Fell, Charlene D.
    Shapera, Shane
    Gershon, Andrea S.
    Cox, Gerard
    Halayko, Andrew J.
    Sadatsafavi, Mohsen
    Wilcox, Pearce G.
    To, Teresa
    RESPIRATORY MEDICINE, 2024, 221
  • [6] Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study
    McCoy, Sara S.
    Mukadam, Zubin
    Meyer, Keith C.
    Kanne, Jeffrey P.
    Meyer, Cristopher A.
    Martin, Maria D.
    Sampene, Emmanuel
    Aesif, Scott W.
    Rice, Laurie N.
    Bartels, Christie M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2171 - 2181
  • [7] THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES
    Sebastiani, Marco
    Vacchi, Caterina
    De Pasquale, Lisa
    Cerri, Stefania
    Cassone, Giulia
    Della Casa, Giovanni
    Garofalo, Martina
    Salvarani, Carlo
    Manfredi, Andreina
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1003 - 1003
  • [8] Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features
    Sebastiani, Marco
    Cassone, Giulia
    Vacchi, Caterina
    De Pasquale, Lisa
    Cerri, Stefania
    Della Casa, Giovanni
    Salvarani, Carlo
    Manfredi, Andreina
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Interstitial pneumonia with autoimmune features
    Santhanam, Sham
    Mohanasundaram, Kavitha
    Krishnan, Shanmuganandan
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2020, 50 (03): : 247 - 255
  • [10] Interstitial Pneumonia with Autoimmune Features
    Graney, Bridget A.
    Fischer, Aryeh
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (05) : 525 - 533